In response to a shortage of FDA-approved Folltropin (follicle stimulating hormone [FSH]), the U.S. Food and Drug Administration announced Jan. 31 that it does not intend to object to the temporary importation of Pluset (porcine pituitary-derived follicle stimulating hormone and luteinizing hormone), by Alberta Veterinary Laboratories Ltd./Solvet. Pluset is authorized for marketing in Spain and importation will improve availability of FSH product for U.S. cattle producers who utilize embryo transfer on their operations
Folltropin and Pluset are used for the same purpose, however, the…
